Generic Biosimilar Medicines Association

Making Medicines Affordable

  • Home
  • About GBMA
    • Contact us
    • GBMA Members
    • Guiding principles
    • Code of Practice
      • Code Complaint Committee
      • Event Reporting
        • Educational Events
        • Non-Price Benefit Reports
      • Annual Review
        • 2011
        • 2012
        • 2013
        • 2014
        • 2015
        • 2016
        • 2017
        • 2018
        • 2019
      • Lodging a complaint
    • Media Enquiries
    • Our Objectives
    • Links
  • Advocacy
    • Extended Strategic Agreement
    • Generic Medicines Working Group (GMWG)
    • Submissions
  • Generics
    • Facts and Fallacies
    • Key Figures on Generic Medicines
    • What is a Generic Medicine?
    • Bioequivalence Explained
  • Biosimilars
    • IGBA Global Biosimilars Week
    • GBMA Position on Biosimilars
      • Impact of Biosimilars
      • Switching
      • Pharmacy Substitution
      • Regulation
      • Awareness and Uptake
      • Naming
    • Key Figures on Biosimilars
  • Topics
    • IGBA
    • Price Disclosure
    • Intellectual Property
    • International Trade Agreements
  • News
    • News 2021
    • News 2020
    • News 2019
    • News 2018
    • News 2017
    • News 2016
    • News 2015
    • News 2014
  • GBMA Education
  • COVID-19 Virus
    • COVID-19 Virus: The Facts
You are here: Home / Latest news / News 2021 / Active Ingredient Prescribing – a game changer for patients: Prescription reforms to further support patient safety

Active Ingredient Prescribing – a game changer for patients: Prescription reforms to further support patient safety

February 1, 2021 By Admin

1 February 2021

Canberra, ACT

Canberra: Australia’s patients will be the big winners out of a new law that will prioritise the active ingredient over the brand name of a medicine, for all eligible prescriptions generated under the Pharmaceutical Benefits Scheme (PBS) and Repatriation PBS (RPBS) prescriptions.

The Chief Executive Officer of the Generic and Biosimilar Medicines Association (GBMA), Ms Marnie Peterson, said the reforms, effective from February 01 2021, will support patient safety by making it easier for patients to identify a medicine’s active ingredient and to discuss, with their prescriber or pharmacist, generic alternatives for their medications.  This is particularly valuable during times when a particular brand of medicine is in short supply.

“We congratulate the Minister for Health, Mr Greg Hunt MP, for introducing these changes that will empower patients to better understand the active ingredients of medicines, whilst reducing their out of pocket costs,” Ms Peterson said.

Active Ingredient Prescribing (AIP) aims to increase consumer understanding of their medicines, assist with health literacy and communication, and increase the uptake of generic and biosimilar medicines, whilst retaining choice for both prescribers and patients. By driving further generic and biosimilar uptake, the measure also supports the delivery of savings to an already overwhelmed health budget and is expected to improve the financial stability of the PBS.

The new Independent Chair of GBMA, Ms Jane Halton AO PSM, welcomed Australia’s Active Ingredient Prescribing laws, which brings Australia’s prescribing practices into alignment with  international standards, supporting improvements to patient safety through standardised descriptions of medicines.

“Not only is this reform a game changer for Australian patients,” Ms Halton said. “but it truly showcases the Australian Government’s commitment in empowering patients with more knowledge and a better understanding of their medicines. This is of key importance in the current COVID-19 environment.”

The implementation of the AIP reforms was negotiated by the GBMA as part of its existing strategic agreement with the Australian Government.

Jane Halton AO PSM is the Chair of the Coalition for Epidemic Preparedness Innovationsand Co-Chair of the COVAX initiative. Ms Halton is also a member of Prime Minister’s COVID-19 Coordination Commission advisory committee. ENDS

Further information can be found online at www.pbs.gov.au/info/general/active-ingredient-prescribing

-ENDS-

ABOUT GBMA

The Generic and Biosimilar Medicines Association (GBMA) is the peak representative body of generic and biosimilar medicine suppliers in Australia.

Its members ensure that all Australians are offered high quality generic and biosimilar medicines, whilst providing affordable community health outcomes that benefit all Australians.

For more information, please contact the GBMA – admin@gbma.com.au or visit www.gbma.com.au

ENQUIRIES

Jannette Cotterell
Executive Counsel Australia
0419 204 059
jcotterell@executivecounsel.com.au

Filed Under: News 2021

Our Members

Juno
Juno
Sandoz logo
Sandoz logo
Viatris
Viatris
Arrow logo
Arrow logo
apotex
apotex
Celltrion Healthcare
Celltrion Healthcare
Fresnius Kabi
Fresnius Kabi
Fresnius Kabi
generic_partners
generic_partners
southern_cross
southern_cross
commercial_eyes
commercial_eyes
sinapse
sinapse

Generic Medicines: The Facts

Generic Medicines Facts

Generic medicines are quality medicines at affordable prices. Ask your doctor to prescribe a generic medicine, or ask for a generic medicine next time you take your prescription to the pharmacy. … More…

The promise of Biosimilars

Biosimilars

https://youtu.be/sBDur7xa084   Biosimilars provide a unique opportunity to help manage the growing costs of biological medicines on the PBS. They offer therapeutically equivalent and … More…

Patients and economy to benefit from ‘medicine manufacturing’ roadmap

March 2, 2021

2 March 2021 Canberra, ACT Australia’s peak body for affordable medicines, today welcomed the Government’s launch of … More...

Announcement of Independent Chair

December 9, 2020

9 December 2020 Canberra, ACT Global health policy powerhouse, Jane Halton … More...

Confidence in biosimilar medicines, amongst specialists, GP’s and Pharmacists

December 8, 2020

12 November 2020 Canberra, ACT New research shows prescriber … More…

© 2021 Generic Medicines Industry Association Pty Ltd | Site Map | Contact Us